Antibiotics and Bacterial Infections

Kevin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has evolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods, and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial, and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

overt chemical, biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy, and Chemical and Biological Depopulation.

Dr. Filutowicz from the Bacteriology Department of the University of Wisconsin-Madison conceived the core technology. Start and Promotion Dates Assistant Professor: 1987 Associate Professor: 1993 Full Professor: 1999 Education M.S. 1975 the University of Warsaw and Polish Academy of Sciences, Warsaw Ph.D. 1979 Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw Postdoctoral Research: University of California-San Diego Areas of Study "Reproductive cycle" and biology of plasmids, anti-microbial agents, bio-therapeutics Teaching Microbiology 470: Microbial Genetics & Molecular Machines

"Reproductive cycle" and biology of plasmids, anti-microbial agents, bio-therapeutics

Mario A Bianchet received his Ph.D. from The University of La Plata, Argentine, and performed Postdoctoral studies at Johns Hopkins School of Medicine, where he is now an Assistant Professor of Neurology since 2011. He has published 70 papers in reputed journals. As a structural enzymologist and expert in ligand recognition, he has participated in several seminal structural and mechanistic studies of macromolecules and ligand/macromolecule interactions of biomedical interest. He has significant contributions to different fields, including bioenergetics: F1-ATPase, xenobiotic-response: NADPH: Quinone oxidoreductases, DNA-repair: Uracyl-Glycosylase/inhibitors, carbohydrate-recognition: animal lectins, and late-stage cell-wall biosynthesis: LD-transpeptidases and their complexes with substrates and carbapenems.

My research aims to understand essential relations between macromolecules’ structure and their mechanisms of action in biological processes involved in human diseases. With that goal, I am applying diverse techniques and methods including x-ray scattering and diffraction, as well as computer modeling and simulation to elucidate these relations that will have a direct impact on the understanding, diagnosis, treatment, and prevention of human diseases

Dr. Nassiri is a former Associate Dean of Global Health at Michigan State University (MSU). He also served as MSU director of the Institute of International Health. He is currently a Professor of Pharmacology and Toxicology, a Professor of Family and Community Medicine, and, a lecturer in Global Health, Infectious Diseases, and Tropical Medicine. He currently works on international public health issues and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in HIV/AIDS, TB, and antimicrobial resistance, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic, and Mexico. He had served as an editorial board member for the journal of HIV and AIDS Review. He is currently an editorial board member for AIDS Patient Care and STDs. Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health, and public health interventions at numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships, particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He is the founder of Michigan State University Osteopathic and Primary Health Clinic in Merida, Yucatan, Mexico. He has developed academic and research partnership programs with the Federal University of Para Institute of Tropical Medicine in Belem, Brazil.

Chemotherapy of Tropical Medicine and Infectious Diseases, HIV/AIDS, Antibiotic Resistance, and Global Health.

Kenny L De Meirleir is an Emeritus Professor in Physiology, Pathophysiology, and Medicine. He has examined, diagnosed, and treated almost 20,000 ME/CFS patients in all 5 continents of the world. Currently, his scientific and medical practices are situated in Belgium at Himmunitas and the Nevada Center for Biomedical Research at the University of Nevada (USA).

Physiology, Pathophysiology, and Medicine

Dr.P.Nagaraj has completed his Ph.D,FRHS., at the age of 35 years from Open International University and University of Madras. He is the Director and chief consultant of PMN Pranikha Speciaality clinic, Chennai, India., a premier Orthopaedic Neuro & Sports Medicine Rehabilitation clinic. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of Indian Sports ,Ghaziabad,UP,India..and Various Sports Associations And Federations In India In Both Domestic And International Committees

Paediatric Neurology and On Sports Exercise Sciences

Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Division and De la Parra Mobile Solutions and is former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil. Moreover, he is a member of the Board of Advisors, former COO & Co-founder at RegenerAge® Clinic & RegenerAge® Beauty, a member of the Board of Advisors, former Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging®, What Skin Needs™/WSN International Pty. Ltd. He also serves as a member of the Board of Advisors and is former CMO at ReAnima Advanced Biosciences and is a member of the Board of Advisors and former Digital Media Director at Bioquark, Inc. He is also the former Latin America Region Manager and Digital Strategy adviser at CardiacSense and former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association.

Neuroscience, Regenerative Medicine, Continued Medical Education, Information & Communications Technology, Biotechnology, Social Development

Certified Professional in Healthcare Quality (CPHQ) and in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). Lean Six Sigma Master Black Belted. Recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015.

heart failure management,Cardiology and Vascular medicine